Light chain amyloidosis (AL) is both a disorder of protein conformation and a plasma cell dyscrasia, with secretion of altered light chains that polymerize systemically into amyloid fibrils leading to organ failure. Knowledge of the biological features of amyloid cells and of the mechanisms determining light chain organ targeting and cytotoxicity is improving rapidly. Manipulation of the immune response via passive or active immunotherapy could open new perspectives for the therapy of this complex disorder.
Immune mechanism of AL amyloidosis.
PALLADINI, GIOVANNI;MERLINI, GIAMPAOLO
2004-01-01
Abstract
Light chain amyloidosis (AL) is both a disorder of protein conformation and a plasma cell dyscrasia, with secretion of altered light chains that polymerize systemically into amyloid fibrils leading to organ failure. Knowledge of the biological features of amyloid cells and of the mechanisms determining light chain organ targeting and cytotoxicity is improving rapidly. Manipulation of the immune response via passive or active immunotherapy could open new perspectives for the therapy of this complex disorder.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
